160 related articles for article (PubMed ID: 35412592)
1. Strategies to Identify and Recruit Women at High Risk for Breast Cancer to a Randomized Controlled Trial of Web-based Decision Support Tools.
McGuinness JE; Bhatkhande G; Amenta J; Silverman T; Mata J; Guzman A; He T; Dimond J; Jones T; Kukafka R; Crew KD
Cancer Prev Res (Phila); 2022 Jun; 15(6):399-406. PubMed ID: 35412592
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma
Trivedi MS; Coe AM; Vanegas A; Kukafka R; Crew KD
Cancer Prev Res (Phila); 2017 Aug; 10(8):434-441. PubMed ID: 28611039
[TBL] [Abstract][Full Text] [Related]
3. Patient and Provider Web-Based Decision Support for Breast Cancer Chemoprevention: A Randomized Controlled Trial.
Crew KD; Bhatkhande G; Silverman T; Amenta J; Jones T; McGuinness JE; Mata J; Guzman A; He T; Dimond J; Tsai WY; Kukafka R
Cancer Prev Res (Phila); 2022 Oct; 15(10):689-700. PubMed ID: 35679576
[TBL] [Abstract][Full Text] [Related]
4. Perceptions of Racially and Ethnically Diverse Women at High Risk of Breast Cancer Regarding the Use of a Web-Based Decision Aid for Chemoprevention: Qualitative Study Nested Within a Randomized Controlled Trial.
Jones T; Guzman A; Silverman T; Freeman K; Kukafka R; Crew K
J Med Internet Res; 2021 Jun; 23(6):e23839. PubMed ID: 34100769
[TBL] [Abstract][Full Text] [Related]
5. Qualitative analysis of shared decision-making for chemoprevention in the primary care setting: provider-related barriers.
Jones T; Silverman T; Guzman A; McGuinness JE; Trivedi MS; Kukafka R; Crew KD
BMC Med Inform Decis Mak; 2022 Aug; 22(1):208. PubMed ID: 35927732
[TBL] [Abstract][Full Text] [Related]
6. Comparing Breast Cancer and Cardiovascular Disease Risk and Use of Chemoprevention and Statins among Women with High-risk Breast Lesions.
Lawal KO; Nilan L; Amenta J; McGuinness JE; Kukafka R; Crew KD
Cancer Prev Res (Phila); 2023 Dec; 16(12):661-667. PubMed ID: 37976537
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis.
Wong SM; Stout NK; Punglia RS; Prakash I; Sagara Y; Golshan M
Cancer; 2017 Jul; 123(14):2609-2617. PubMed ID: 28221673
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis.
Hershman D; Sundararajan V; Jacobson JS; Heitjan DF; Neugut AI; Grann VR
J Clin Oncol; 2002 Jan; 20(1):9-16. PubMed ID: 11773148
[TBL] [Abstract][Full Text] [Related]
9. Identifying Women at High Risk for Breast Cancer Using Data From the Electronic Health Record Compared With Self-Report.
Jiang X; McGuinness JE; Sin M; Silverman T; Kukafka R; Crew KD
JCO Clin Cancer Inform; 2019 Mar; 3():1-8. PubMed ID: 30869999
[TBL] [Abstract][Full Text] [Related]
10. The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS.
Valero MG; Zabor EC; Park A; Gilbert E; Newman A; King TA; Pilewskie ML
Ann Surg Oncol; 2020 Mar; 27(3):736-740. PubMed ID: 31559544
[TBL] [Abstract][Full Text] [Related]
11. Making informed choices on incorporating chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial.
Crew KD; Anderson GL; Arnold KB; Stieb AP; Amenta JN; Collins N; Law CW; Pruthi S; Sandoval-Leon A; Bertoni D; Grosse Perdekamp MT; Colonna S; Krisher S; King T; Yee LD; Ballinger TJ; Braun-Inglis C; Mangino D; Wisinski KB; DeYoung CA; Ross M; Floyd J; Kaster A; Vander Walde L; Saphner T; Zarwan C; Lo S; Graham C; Conlin A; Yost K; Agnese D; Jernigan C; Hershman DL; Neuhouser ML; Arun B; Kukafka R
Contemp Clin Trials; 2024 May; 142():107564. PubMed ID: 38704119
[TBL] [Abstract][Full Text] [Related]
12. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
13. Extraction of Electronic Health Record Data using Fast Healthcare Interoperability Resources for Automated Breast Cancer Risk Assessment.
McGuinness JE; Zhang TM; Cooper K; Kelkar A; Dimond J; Lorenzi V; Crew KD; Kukafka R
AMIA Annu Symp Proc; 2021; 2021():843-852. PubMed ID: 35308910
[TBL] [Abstract][Full Text] [Related]
14. Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer chemoprevention.
Crew KD; Silverman TB; Vanegas A; Trivedi MS; Dimond J; Mata J; Sin M; Jones T; Terry MB; Tsai WY; Kukafka R
Contemp Clin Trials Commun; 2019 Dec; 16():100433. PubMed ID: 31497674
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.
Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA
Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065
[TBL] [Abstract][Full Text] [Related]
16. A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system.
Knerr S; Wernli KJ; Leppig K; Ehrlich K; Graham AL; Farrell D; Evans C; Luta G; Schwartz MD; O'Neill SC
Contemp Clin Trials; 2017 May; 56():25-33. PubMed ID: 28257920
[TBL] [Abstract][Full Text] [Related]
17. A System-Level Approach to Improve the Uptake of Antiestrogen Preventive Therapy among Women with Atypical Hyperplasia and Lobular Cancer
Brewster AM; Thomas P; Brown P; Coyne R; Yan Y; Checka C; Middleton L; Do KA; Bevers T
Cancer Prev Res (Phila); 2018 May; 11(5):295-302. PubMed ID: 29618460
[No Abstract] [Full Text] [Related]
18. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease.
Page DL; Kidd TE; Dupont WD; Simpson JF; Rogers LW
Hum Pathol; 1991 Dec; 22(12):1232-9. PubMed ID: 1748429
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor.
Flanagan MR; Zabor EC; Stempel M; Mangino DA; Morrow M; Pilewskie ML
Ann Surg Oncol; 2019 Jul; 26(7):2127-2135. PubMed ID: 30815800
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
